Each injection maintains GLP-1 receptor activation, suppressing appetite and slowing gastric emptying
The "Beyond-Use Date" (BUD) is assigned to ensure safety and potency within a shorter, validated timeframe
If regulatory changes eliminate access to compounded semaglutide, patients would need to transition to brand-name products (Wegovy, Ozempic, or Rybelsus) or explore alternative weight loss approaches
injections: How they compare Both use the same active ingredienttirzepatideand work through similar mechanisms to regulate appetite, glucose, and metabolism
At InjectCo, these medications are used within a structured weight loss program that begins with an online evaluation and includes ongoing clinical oversight
Data were pooled using random-effects models, and subgroup analyses were performed by drug type and treatment duration